 The Next Regeneration
Biocomposites is a privately held pioneering developer, manufacturer and distributor of synthetic, tissue regeneration products. The company has developed a broad range of products that addresses the clinical and economic needs of medical specialties in orthopaedics and dentistry. Research, manufacturing, marketing and international sales are directed from the company's headquarters in Keele, UK. Sales companies are also based in Wilmington, NC and Shanghai.
Biocomposites unrivalled knowledge of calcium technologies has led to the development of geneX. A unique, fully resorbable bone graft material with a controlled, reproducible, negative surface charge. This stimulates the gene expression of proteins which directs the adhesion and proliferation of bone forming cells for rapid osteogenesis and bone formation. geneX is the only stand alone material other than BMPs to achieve posterolateral fusion in the New Zealand White rabbit “Boden” model.
Visit us at EuroSpine, booth 25.
Biocomposites LtdTel: +44 (0) 1782 338580 Web: www.biocomposites.com |
|
Cadisc™-L
Cadisc™-L, from Ranier Technology is the revolutionary, new single unit elastomeric Lumbar Disc Arthroplasty device for the treatment of degenerative disc disease in the lumbar spine.
Unique in design, it has a graduated stiffness from nucleus to annulus, with no (debris generating) articulating components. Biomechanical testing shows that the unique visco-elastic nature of the Cadisc™-L provides a moving centre of rotation, mimicking the physiological characteristics of the natural disc, thus giving the potential for reduced adjacent segment degeneration.
Unlike other lumbar disc replacement devices, Cadisc™-L has no metal end-plates. Instead, the end plate surfaces, (which incorporate calcium phosphate-coated low-profile fixation ribs) are similar in modulus to the vertebral end-plates, with the potential to minimise stress shielding within the adjacent vertebrae.
Tantalum markers, located on the end plates superiorly and inferiorly, allow for X-ray visualisation and optimal implant positioning is facilitated by the Surgeon-designed user friendly instrumentation.
Ranier Technology LimitedTel: +44 (0)1223 505045 Fax: +44 (0)1223 505046 Web: www.ranier.co.uk E-mail: info@ranier.co.uk |
|
The Spinos Implant
Spinos is an innovative implant for use in the treatment of low back pain. It enables the distance between the spinous processes to be maintained, while preserving full mobility.
The in-situ continuous adjustability of the interspinous distance affords dynamic stabilisation of the spinal motion segment, whilst effectively preventing narrowing of the neural foramina and excessive loading of the facet joints. At the same time all anatomical structures, including the supraspinous ligament, are preserved intact.
With the infinitely variable adjustability of distance in-situ, the functional requirements of the individual spinal motion segment can be re-established. At the same time, flexible contact areas on the spinous processes help to prevent bony atrophy and peak loading. The cone shaped, tapered point facilitates insertion of the implant into the interspinous space.
Bevelled edges allow good adaptation to the existing individual anatomy and permit simultaneous application at adjacent levels. The implant is placed in the interspinous space using the combined holder-distractor forceps and expanded until the adequate supraspinous ligament tension is restored or the vertebral end plates are parallel, respectively. Through this gentle approach, the anatomical structures are preserved intact, kyphosis is prevented and peak loading of the spinous processes is avoided.
UK Distributor:
Lindare MedicalTel: +44 (0)1233 770370 Fax: +44 (0)1233 770370 Web: www.lindaremedical.co.uk E-mail: customerservices@lindaremedical.co.uk |
|
SmartCage Expandable Controllable TLIF Cage
Dedicated to the Transforaminal ApproachIt minimises dural exposure, reduces iatrogenic neurologic lesion risks due to excessive root traction and avoids dissection of epidural scar during revision surgeries. Unique Expansion Feature Ease cage insertion even in severely collapsed disc spaces and asymmetric discopathy. Avoid subsidence risk inside endplates during progression. Anatomic Biconvex Shape Perfectly adapted to the natural disc space, provides ample contacting surfaces and restores natural lordosis. Optimum Fusion Conditions Bone graft is transferred to the opposed lateral space. Additional bone graft material is inserted through the lateral window and all around the cage to entirely fill the disc space and ensure optimal fusion conditions. UK Distributor: Lindare Medical Tel: +44 (0)1233 770370 Fax: +44 (0)1233 770370 Web: www.lindaremedical.co.uk E-mail: customerservices@lindaremedical.co.uk |
|
The M6®-C Artificial Cervical Disc
Tel: +44 (0)1233 770370 Fax: +44 (0)1233 770370 Web: www.lindaremedical.co.uk E-mail: customerservices@lindaremedical.co.uk | ||
|
M6-L: Designed to Replicate the Motion of a Natural Disc
The M6-L artificial lumbar disc is designed to replicate the anatomic structure and biomechanical performance of a natural disc. Its innovative design incorporates an artificial nucleus to allow axial compression and a woven fiber annulus for controlled range of motion in all six degrees of freedom. This physiologic motion is intended to preserve segmental motion and possibly prevent or delay additional adjacent level degeneration.
Quality of Motion assesses how well the motion of an implanted functional spine unit approximates the motion of a healthy one over the entire range of motion, not just its endpoints. Through biomechanical testing, a load vs. angular displacement curve (“kinematic signature”) is generated that allows assessment of the Quality of Motion parameters.
Biomechanical testing with the M6-L artificial lumbar disc has demonstrated equivalent Quality of Motion compared to the healthy disc. The innovative artificial fiber annulus and nucleus construct of the M6-L is the critical component in replicating this physiologic motion, as it is designed to provide the necessary restraint and control needed throughout the spine’s natural range of motion.
UK Distributor:
Lindare MedicalTel: +44 (0)1233 770370 Fax: +44 (0)1233 770370 Web: www.lindaremedical.co.uk E-mail: customerservices@lindaremedical.co.uk |
|
Activity of a back orthosis in osteoporosis demonstrated scientifically
A quarter of all women aged over 50 suffer from at least one fracture of a vertebral body due to osteoporosis. A clinical study has demonstrated for the first time that an orthopaedic aid is an effective treatment for this condition, even though this is normally a process for drug treatments.
The back orthosis Spinomed gave sensational results (published in the American Journal of Physical Medicine & Rehabilitation, March 2004).1
The study (crossover design) was performed on 62 female patients (average age of 73 years) for 12 month, who had already suffered an average of two vertebral body fractures.
Results: Use of the back orthosis increased muscular strength in the trunk and thus improved posture.
The humpback was clearly improved and the kyphosis angle decreased by 11%. Height increased by a mean of 6 mm. The increase in muscular strength improved stability when standing and this prevented falls and further bone fractures.
The patients also reported that their quality of life had improved. They suffered less pain, had to take fewer breaks for a rest during the day and felt more energetic.
The most convincing result was patient satisfaction, as 90% of the women did not wish to return the orthosis after completing the study.
Thus, Spinomed is the first orthosis with efficacy demonstrated in an evidence-based study.
Web: www.medi.de |
|
Orthoclot – Absorbable Polysaccharide Surgical Haemostat
OrthoClot™ Polysaccharide Haemostatic System Administrator (PHS) is a natural plant-based haemostatic system composed of Absorbable Modified Polymer (AMP™). OrthoClot™ is intended as an absorbable haemostatic system to control bleeding during orthopaedic surgery including Spinal Surgery, Bone Tumour Resection, and Complete Knee Replacement Surgery etc.
Total AMP™ absorption occurs rapidly within several days and is dependent on the amount of material applied and the site of use. AMP™ particles are degraded by histamines, including amylase and glucoamylase in the human body.
The OrthoClot™ product is delivered to the sterile field in a double barrier, sterile pouch. The AMP™ particles are then delivered to the surgical site with a Standard (100mm or 200mm) polypropylene applicator which requires no mixing or preparation whatsoever.
OrthoClot™ PHS is CE marked and registered in major international markets. OrthoClot™ is non-pyrogenic and latex-free.
UK Distributor:
Lindare MedicalTel: +44 (0)1233 770370 Fax: +44 (0)1233 770370 Web: www.lindaremedical.co.uk E-mail: customerservices@lindaremedical.co.uk |
